Patents by Inventor Richard L. Bowen

Richard L. Bowen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210275625
    Abstract: Method of modulating the concentrations of tau, P-tau, ?-amyloid, NF-L, ?-synuclein and/or neurogranin in cerebrospinal fluid (CSF) to prevent, stabilize and/or reverse suitable health conditions.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Applicant: Richard L. Bowen
    Inventors: Richard L. BOWEN, Craig S. ATWOOD
  • Publication number: 20180092960
    Abstract: Method of modulating the concentrations of tau, P-tau, ?-amyloid, NF-L, ?-synuclein and/or neurogranin in cerebrospinal fluid (CSF) to prevent, stabilize and/or reverse suitable health conditions.
    Type: Application
    Filed: October 3, 2017
    Publication date: April 5, 2018
    Inventor: Richard L. Bowen
  • Publication number: 20110230399
    Abstract: The present invention relates to methods and products for the treatment of obesity. The invention discloses a method of treating obesity related disease in a mammal in need of such treatment comprising administering to the mammal a therapeutically effective amount of a composition which causes the continued down regulation of the NPY-1 or NPY-5 receptor.
    Type: Application
    Filed: November 24, 2009
    Publication date: September 22, 2011
    Inventor: Richard L. Bowen
  • Publication number: 20100267620
    Abstract: The present invention relates to a method for slowing, preventing or delaying senescence or treating or preventing a disease associated with senescence by administering a therapeutically effective amount of at least one physiological agent that decreases or regulates the blood level, production, function or activity of LH or FSH, or that decreases or regulates the production or activity of activin, or that increases or regulates the blood level, production, function, or activity of inhibin or follistatin.
    Type: Application
    Filed: March 22, 2010
    Publication date: October 21, 2010
    Applicant: Voyager Pharmaceutical Corporation
    Inventor: Richard L. Bowen
  • Publication number: 20030144203
    Abstract: The present invention relates to a method for slowing, preventing or delaying senescence or treating or preventing a disease associated with senescence by administering a therapeutically effective amount of at least one physiological agent that decreases or regulates the blood level, production, function or activity of LH or FSH, or that decreases or regulates the production or activity of activin, or that increases or regulates the blood level, production, function, or activity of inhibin or follistatin.
    Type: Application
    Filed: December 18, 2002
    Publication date: July 31, 2003
    Applicant: Voyager Pharmaceutical Corporation
    Inventor: Richard L. Bowen